<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37740629</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2980-3187</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Tuberkuloz ve toraks</Title><ISOAbbreviation>Tuberk Toraks</ISOAbbreviation></Journal><ArticleTitle>Risk factors for post-acute sequelae of COVID-19 in hospitalized patients: An observational study based on a survey in a tertiary care center in T&#xfc;rkiye.</ArticleTitle><Pagination><StartPage>261</StartPage><EndPage>272</EndPage><MedlinePgn>261-272</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20239707</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5578/tt.20239707</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Long COVID is a multisystem disease with various symptoms and risk factors. We aim to investigate the post-acute sequelae of COVID-19 and related risk factors in a tertiary care center.</AbstractText><AbstractText Label="MATERIALS AND METHODS">In this observational study, based on a survey of 1.977 COVID-19 patients hospitalized from April 2020 to January 2021, a retrospective assessment was carried out on 1.050 individuals who were reachable via telephone to determine their eligibility for meeting the inclusion criteria.</AbstractText><AbstractText Label="RESULTS">The data of 256 patients who reported at least one persistent symptom were analyzed. Long COVID prevalence was 24.3%. Among 256 patients (median age 52.8; 52.7% female; 56.63% had at least one comorbidity), dyspnea, fatigue, arthralgia-myalgia, cough, and back pain were the most common post-acute sequelae of COVID-19 (42.4%; 28.29%; 16.33%; 13.15% and 7.17%, respectively). The risk factors for the persistence of dyspnea included having lung diseases such as chronic obstructive pulmonary disease, a history of intensive care support, the requirement for long-term oxygen therapy, and a history of cytokine storm (p= 0.024, p= 0.026, p&lt; 0.001, p= 0.036, p= 0.005, respectively). The correlation between lung involvement with post-discharge cough (p= 0.041) and dizziness (p= 0.038) was significant. No correlation between the symptoms with the severity of acute infection, age, and gender was found. When a multivariate regression analysis was conducted on the most common long COVID-related symptoms, several independent risk factors were identified. These included having lung disease for dyspnea (OR 5.81, 95% CI 1.08-31.07, p= 0.04); length of hospital stay for myalgia (OR 1.034, 95% CI 1.004-1.065, p= 0.024); and pulmonary involvement of over 50% during COVID-19 infection for cough (OR 3.793, 95% CI 1.184-12.147, p= 0.025).</AbstractText><AbstractText Label="CONCLUSION">COVID-19 survivors will require significant healthcare services due to their prolonged symptoms. We hope that our findings will guide the management of these patients in clinical settings towards best practices.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Y&#x131;ld&#x131;z</LastName><ForeName>Ye&#x15f;im</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Gazi University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zt&#xfc;rk &#x15e;ahin</LastName><ForeName>Burcu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Clinic of Pulmonary, &#x15e;ehitkamil State Hospital, Gaziantep, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demir</LastName><ForeName>Mert Can</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Gazi University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demir</LastName><ForeName>&#x15e;erife</ForeName><Initials>&#x15e;</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Gazi University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;iftci</LastName><ForeName>Beyza</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Gazi University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf6;kt&#xfc;rk</LastName><ForeName>Nurdan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Gazi University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulukavak &#xc7;ift&#xe7;i</LastName><ForeName>Tansu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Gazi University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yurdakul</LastName><ForeName>Ahmet Selim</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Gazi University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Y&#x131;lmaz Demirci</LastName><ForeName>Nilg&#xfc;n</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Gazi University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydo&#x11f;du</LastName><ForeName>M&#xfc;ge</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Gazi University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dizbay</LastName><ForeName>Murat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Gazi University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x11f;uz&#xfc;lgen</LastName><ForeName>&#x130;pek K&#x131;v&#x131;lc&#x131;m</ForeName><Initials>&#x130;K</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Gazi University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Hastanede yatan hastalarda akut COVID-19 sonras&#x131; sekeller i&#xe7;in risk fakt&#xf6;rleri: T&#xfc;rkiye&#x2019;de &#xfc;&#xe7;&#xfc;nc&#xfc; basamak bir sa&#x11f;l&#x131;k merkezinde ankete dayal&#x131; g&#xf6;zlemsel bir &#xe7;al&#x131;&#x15f;ma.</VernacularTitle></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Tuberk Toraks</MedlineTA><NlmUniqueID>0417364</NlmUniqueID><ISSNLinking>0494-1373</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000359" MajorTopicYN="N">Aftercare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="tur"><AbstractText Label="&#xd6;Z">Hastanede yatan hastalarda akut COVID-19 sonras&#x131; sekeller i&#xe7;in risk fakt&#xf6;rleri: T&#xfc;rkiye&#x2019;de &#xfc;&#xe7;&#xfc;nc&#xfc; basamak bir sa&#x11f;l&#x131;k merkezinde ankete dayal&#x131; g&#xf6;zlemsel bir &#xe7;al&#x131;&#x15f;ma</AbstractText><AbstractText Label="GIRI&#x15e;">Uzam&#x131;&#x15f; COVID, &#xe7;e&#x15f;itli semptomlar&#x131; ve risk fakt&#xf6;rleri olan bir &#xe7;oklu sistem hastal&#x131;&#x11f;&#x131;d&#x131;r. Bu &#xe7;al&#x131;&#x15f;ma ile &#xfc;&#xe7;&#xfc;nc&#xfc; basamak bir merkezde COVID-19&#x2019;un akut sonras&#x131; sekellerini ve ilgili risk fakt&#xf6;rlerini ara&#x15f;t&#x131;rmay&#x131; ama&#xe7;lad&#x131;k.</AbstractText><AbstractText Label="MATERYAL VE METOD">Bir ankete dayanan bu g&#xf6;zlemsel &#xe7;al&#x131;&#x15f;mada, 2020 Nisan&#x2019;dan 2021 Ocak&#x2019;a kadar hastanede yatarak takip edilen 1,977 COVID-19 hastas&#x131;ndan telefonla ula&#x15f;&#x131;labilen 1,050&#x2019;si dahil etme kriterlerine uygunluk a&#xe7;&#x131;s&#x131;ndan geriye d&#xf6;n&#xfc;k olarak de&#x11f;erlendirildi. Taburculuk sonras&#x131; en az sekiz hafta devam eden en az bir uzam&#x131;&#x15f; semptom bildiren 256 hastan&#x131;n verileri analiz edildi.</AbstractText><AbstractText Label="BULGULAR">Uzam&#x131;&#x15f; COVID prevalans&#x131; %24,3 bulundu. 256 hasta aras&#x131;nda (medyan ya&#x15f; 52,8; %52,7 kad&#x131;n; %56,63&#x2019;&#xfc;nde en az bir komorbidite vard&#x131;); nefes darl&#x131;&#x11f;&#x131;, yorgunluk, artralji-kas a&#x11f;r&#x131;s&#x131;, &#xf6;ks&#xfc;r&#xfc;k ve s&#x131;rt a&#x11f;r&#x131;s&#x131; COVID-19&#x2019;un akut sonras&#x131; en yayg&#x131;n sekelleriydi (s&#x131;ras&#x131;yla %42,4; %28,29; %16,33; %13,15 ve %7,17). Kronik obstr&#xfc;ktif akci&#x11f;er hastal&#x131;&#x11f;&#x131; ba&#x15f;ta olmak &#xfc;zere akci&#x11f;er hastal&#x131;&#x11f;&#x131; tan&#x131;s&#x131; olmak, yo&#x11f;un bak&#x131;m deste&#x11f;i &#xf6;yk&#xfc;s&#xfc;, uzun s&#xfc;reli oksijen tedavisi ihtiyac&#x131; ve sitokin f&#x131;rt&#x131;nas&#x131; &#xf6;yk&#xfc;s&#xfc; olmak, nefes darl&#x131;&#x11f;&#x131;n&#x131;n devam etmesi i&#xe7;in risk fakt&#xf6;rleriydi (s&#x131;ras&#x131;yla p= 0,024, p= 0,026, p&lt; 0,001, p= 0,036, p= 0,005). Akci&#x11f;er tutulumu ile taburculuk sonras&#x131; &#xf6;ks&#xfc;r&#xfc;k (p= 0,041) ve ba&#x15f; d&#xf6;nmesi (p= 0,038) aras&#x131;ndaki ili&#x15f;ki anlaml&#x131;yd&#x131;. Semptomlar ile akut enfeksiyonun &#x15f;iddeti, ya&#x15f; ve cinsiyet aras&#x131;nda bir ili&#x15f;ki bulunmad&#x131;. Uzam&#x131;&#x15f; COVID ile en s&#x131;k ili&#x15f;kili semptomlar i&#xe7;in &#xe7;ok de&#x11f;i&#x15f;kenli regresyon analizi yapt&#x131;&#x11f;&#x131;m&#x131;zda, akci&#x11f;er hastal&#x131;&#x11f;&#x131;na sahip olman&#x131;n (OR 5,81, %95 GA 1,08-31,07, p= 0,04) nefes darl&#x131;&#x11f;&#x131;; hastanede kal&#x131;&#x15f; s&#xfc;resinin (OR 1,034, %95 GA 1,004-1,065, p= 0.024) miyalji ve COVID-19 enfeksiyonu s&#x131;ras&#x131;nda &gt;%50 akci&#x11f;er tutulumu olmas&#x131;n&#x131;n (OR 3,793, %95 GA 1,184- 12,147, p= 0,025) &#xf6;ks&#xfc;r&#xfc;k i&#xe7;in ba&#x11f;&#x131;ms&#x131;z risk fakt&#xf6;rleri oldu&#x11f;unu saptad&#x131;k.</AbstractText><AbstractText Label="SONU&#xc7;">COVID-19 ge&#xe7;iren hastalar uzayan semptomlar&#x131; nedeniyle sa&#x11f;l&#x131;k sistemlerinde &#xf6;nemli y&#xfc;k olu&#x15f;turacaklard&#x131;r. Bulgular&#x131;m&#x131;z&#x131;n bu hastalar&#x131;n kliniklerde y&#xf6;netiminde, en iyi uygulamalara rehberlik edece&#x11f;ini umuyoruz.</AbstractText></OtherAbstract><CoiStatement>
The authors declare that they have no conflict of interest.
</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>23</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37740629</ArticleId><ArticleId IdType="pmc">PMC10854058</ArticleId><ArticleId IdType="doi">10.5578/tt.20239707</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
National Institute for Health and Care Excellence (NICE)
  London: COVID-19 rapid guideline: Managing the long-term effects of COVID-19.  https://www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus . Lancet Infect Dis . 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention (CDC)
  United States: Long COVID or Post-COVID Conditions.  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html</Citation></Reference><Reference><Citation>
PASC Dashboard
  
America: American Academy of
Physical Medicine and Rehabilitation (AAPM&amp;R)
.  https://pascdashboard.aapmr.org/</Citation></Reference><Reference><Citation>
Office for National Statistics
  
United Kingdom: Prevalence
of ongoing symptoms following coronavirus (COVID-19)
infection in the UK
.  
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocial%02care/conditionsanddiseases/bulletins/prevalenceofongo%02ingsymptomsfollowingcoronaviruscovid19infectionin%02theuk/4august2022
</Citation></Reference><Reference><Citation>
National Institute for Health and Care Research (NIHR)
  
United Kingdom: Living with COVID-19 - Second review
.  
https://evidence.nihr.ac.uk/themedre%02view/living-with-covid19-second-review/
</Citation></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-Acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms . Front Microbiol . 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention (CDC)
  
United States: Post-COVID Conditions: Information for
Healthcare Providers
. 
2022
 
https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid%20management.html
</Citation></Reference><Reference><Citation>
National Institutes of
Health (NIH)
  
COVID-19 treatment guidelines: Clinical spectrum of
SARS-CoV-2 infection.
.  
https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/
</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D., Salah Eldin H., Taeimah M., Khattab R., Salem R. The COVID-19 Cytokine Storm; What We Know So Far . Front Immunol . 2020;11:1446. doi: 10.3389/fimmu.2020.01446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01446</ArticleId><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S., Hosseiniyan Khatibi S.M., Hejazi M.S., Tarhriz V., Farjami A., Ghasemian Sorbeni F. COVID-19 infection: An overview on cytokine storm and related interventions . Virol J . 2022;19:92. doi: 10.1186/s12985-022-01814-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01814-1</ArticleId><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention (CDC)
  
United States: Long COVID or Post-COVID Conditions
.  
https://www.cdc.gov/coronavi-rus/2019-ncov/long-term-effects/index.html
</Citation></Reference><Reference><Citation>Hosmer D.W., Jr. Lemeshow S., Sturdivant R.X. Applied Logistic Regression . 2013;177 doi: 10.1002/9781118548387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9781118548387</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review . J Infect Dis . 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X. Six-month consequences of COVID-19 in patients discharged from hospital: A cohort study . Lancet . 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C. Pathophysiology and mechanism of long COVID: A comprehensive review . Ann Med . 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Argun Baris S., Baydar Toprak O., Duru Cetinkaya P., Fakili F., Kokturk N., Kul S. The predictors of long-COVID in the Turkish Thoracic Society-TURCOVID multicenter registry cohort: One-year follow-up results . Asian Pac J Trop Med . 2022;15:400&#x2013;409. doi: 10.3390/jcm9123993.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9123993</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt C. COVID-19 long haulers . Nat Biotechnol . 2021;39:908&#x2013;913. doi: 10.1038/s41587-021-00984-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-00984-7</ArticleId><ArticleId IdType="pmc">PMC8277229</ArticleId><ArticleId IdType="pubmed">34257426</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 . PLoS Med . 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward H., Flower B., Garcia P.J., Ong S.W.X., Altmann D.M., Delaney B. Global surveillance, research, and collaboration needed to improve understanding and management of long COVID . Lancet . 2021;398:2057&#x2013;2059. doi: 10.1016/S0140-6736(21)02444-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02444-2</ArticleId><ArticleId IdType="pmc">PMC8580495</ArticleId><ArticleId IdType="pubmed">34774190</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: A systematic review . JAMA Netw Open . 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R. Sequelae in adults at 6 months after COVID-19 infection . JAMA Netw Open . 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Kelly J.D., Lu S., Goldberg S.A., Davidson M.C., Mathur S. Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: Cohort description and approaches for measurement . Open Forum Infect Dis . 2021;9:ofab640. doi: 10.1152/japplphysiol.00138.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00138.2022</ArticleId><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation . J Med Virol . 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sar&#x131;o&#x11f;lu N., Aksu G.D., &#xc7;oban H., B&#xfc;lb&#xfc;l E., Demirpolat G., Arslan A.T. Clinical and radiological outcomes of long-COVID: Is the post-COVID fibrosis common? . Tuberk Toraks. 2023;71:48&#x2013;57. doi: 10.5578/tt.20239907.</Citation><ArticleIdList><ArticleId IdType="doi">10.5578/tt.20239907</ArticleId><ArticleId IdType="pmc">PMC10795271</ArticleId><ArticleId IdType="pubmed">36912409</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell . 2022;185:881&#x2013;895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C. What&#x2019;s going on following acute COVID- 19? Clinical characteristics of patients in an out-patient rehabilitation program . Nat Commun . 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis . Sci Rep . 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection . PLoS One . 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson K.B., Rao M., Bonilla H., Subramanian A., Hack I., Madrigal M. Patients with uncomplicated Coronavirus Disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: A cautionary tale during a global pandemic . Clin Infect Dis . 2021;73:e826&#x2013;e826. doi: 10.1093/cid/ciab103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;ahin M.M., Uzuno&#x11f;lu E., Yal&#xe7;in M., Cesur G., Yildiz M., Aysert Yildiz P. Assessment of olfactory and gustatory functions in COVID-19 patients . Turk J Med Sci . 2021;51:2296&#x2013;2303. doi: 10.3906/sag-2102-290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-2102-290</ArticleId><ArticleId IdType="pmc">PMC8742490</ArticleId><ArticleId IdType="pubmed">34333903</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H. Risk factors associated with long COVID syndrome: A retrospective study . Iran J Med Sci . 2021;46:428&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Zaslavsky M., Su Y., Sikora M.J., van Unen V., Christophersen A. Human KIR + CD8 + T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19 . bioRxiv . 2021:2021.12.23.473930.</Citation></Reference><Reference><Citation>Su Y., Chen D., Yuan D., Lausted C., Choi J., Dai C.L. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19 . Cell . 2020;183:1479&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598382</ArticleId><ArticleId IdType="pubmed">33171100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.W., Su Y., Baloni P., Chen D., Pavlovitch-Bedzyk A.J., Yuan D. Integrated plasma and single immune cell analysis uncover metabolic changes in individuals with COVID-19 . Nat Biotechnol . 2022;40:110&#x2013;120. doi: 10.1038/s41587-021-01020-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-01020-4</ArticleId><ArticleId IdType="pmc">PMC9206886</ArticleId><ArticleId IdType="pubmed">34489601</ArticleId></ArticleIdList></Reference><Reference><Citation>Shemesh A., Su Y., Calabrese D.R., Chen D., Arakawa-Hoyt J., Roybal K.T. Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting Fc&#x3b5;RI&#x3b3; expression . J Exp Med . 2022;219:e20220551. doi: 10.1084/jem.20220551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20220551</ArticleId><ArticleId IdType="pmc">PMC9448639</ArticleId><ArticleId IdType="pubmed">36066491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;mer B., Knoll R., Bonaguro L., ToVinh M., Raabe J., Astaburuaga-Garc&#xed;a R. Early IFN-&#x3b1; signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 . Immunity . 2021;54:2650&#x2013;2669. doi: 10.1016/j.immuni.2021.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.09.002</ArticleId><ArticleId IdType="pmc">PMC8416549</ArticleId><ArticleId IdType="pubmed">34592166</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>